Intake Breathing Gets $62M For Magnetic Nasal Strips
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Intake Breathing has received a $62 million investment from Camino Partners, its first significant outside capital infusion, according to Athletech News. The company says it plans to use the funding to expand into physical retail and specialty channels and hire for growth; the investment terms and expansion timeline have not been disclosed.

Intake Breathing has received a $62 million investment from Camino Partners, the firm founded by Kind Snacks creator Daniel Lubetzky, as the company plans to expand sales of its magnetic nasal dilator into physical retail and specialty channels. Athletech News reported the deal as Intake’s first significant outside capital infusion; the amount of equity or other financing terms was not disclosed.

Before you orderOffer from Amazon

Get workout gear delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Intake makes a reusable magnetic band used with adhesive tabs to mechanically open the nasal valve, the narrowest part of the nasal airway. The company positions this system as an alternative to conventional adhesive nasal strips. The funding report describes how the product is designed to work, but does not provide clinical evidence or independent findings about its effects on airflow, sleep, athletic performance or health.

The company has built its business primarily through direct-to-consumer sales. It says the new investment will support entry into physical retail and specialty channels, alongside key hires. The report does not name retailers, identify the roles Intake intends to fill, or provide a schedule for those plans.

Intake was founded by inventor and medical device engineer Jim Castillo and is led by co-founder and chief executive Alex Hauck, Castillo’s son-in-law. The report identifies Los Angeles Dodgers pitcher Justin Wrobleski and Belgian soccer player Amadou Onana among professional athletes who have attracted attention to the brand. It does not specify whether they are customers, paid partners or formal endorsers.

At a glance
announcementWhen: Investment announced in the source repo…
The developmentCamino Partners has invested $62 million in Intake Breathing as the nasal device company prepares to expand beyond direct-to-consumer sales.

A Retail Push for Nasal Devices

The investment gives Intake substantial backing as it seeks to move from an online-led business into in-person retail. That shift could put the product in front of shoppers who may not have encountered magnetic nasal devices through the company’s own sales channels. Whether the funding translates into broad availability will depend on retail partnerships and execution, neither of which has been detailed.

The deal also signals Camino Partners’ interest in consumer wellness products tied to sleep, recovery and performance. Camino has investments in businesses including boutique fitness brand Barry’s and nonalcoholic beer maker Athletic Brewing, according to the source report. Its bet on Intake reflects an effort to build a consumer market for nasal breathing products; it does not establish that the device produces the health or performance outcomes sometimes associated with breathing optimization.

For consumers, the immediate development is a financing and expansion announcement, not a change to the product or a new medical finding. The reported plans may eventually affect where the device is sold, but availability, pricing and product evidence remain separate questions.

Products Worth Considering

As an affiliate, we earn on qualifying purchases.

From Family Business to Expansion

Intake began as a solution developed by Castillo, and the company remained a family-run business before this investment, according to Athletech News. Hauck described the origin as a problem his father-in-law addressed in his garage. The report characterizes the $62 million financing as the company’s first significant outside capital, marking a new stage in its growth.

The product is intended to open the nasal valve mechanically. Unlike a conventional adhesive strip that adheres across the nose, Intake’s system pairs a reusable magnetic band with adhesive tabs. This distinction describes the product’s construction; the source report does not compare its results with traditional strips or other approaches in a clinical trial.

Camino’s founder, Lubetzky, drew a comparison with the development of Kind, saying his firm sees an opportunity to make nasal breathing products a more regular part of consumer wellness routines. That is Camino’s market thesis, rather than evidence that nasal breathing devices are becoming an everyday category or that consumers will adopt Intake at scale.

“We’re not just gaining capital, we’re gaining a partner who knows exactly what it takes to help get us there.”

— Alex Hauck, Intake Breathing co-founder and CEO

Deal Terms and Rollout Details

The source report does not say whether the $62 million is an equity investment, a mix of financing instruments or another arrangement, and it does not disclose the company’s valuation or Camino’s ownership stake. It also does not specify when the transaction closed or whether other investors participated.

Intake has not named retail partners, launch dates, planned hiring numbers or sales targets in the reported announcement. The company’s plans for physical and specialty retail are stated, but the scale and timing of expansion remain unknown.

The report also does not supply independent testing or clinical evidence establishing specific effects of the magnetic device. Its description of the product’s intended mechanical action should not be treated as proof of improved sleep, recovery or athletic performance. The status of the athletes mentioned in the report as users or endorsers is also unspecified.

Retail Plans and Hiring

The next developments to watch are announcements naming retail or specialty-channel partners, the timing of product availability, and the hires Intake says it plans to make. The company may also provide further information about how the funding will be allocated, though no such details or timetable are included in the source report.

Any assessment of the investment’s impact will depend on whether Intake can grow beyond direct-to-consumer sales and establish broader distribution. For now, the confirmed development is the reported $62 million backing and the company’s stated expansion intentions; rollout milestones and commercial results have not been reported.

Key Questions

Who invested $62 million in Intake Breathing?

Camino Partners, the investment firm founded by Daniel Lubetzky, made the investment, according to Athletech News.

What does Intake Breathing sell?

Intake sells a magnetic nasal dilator consisting of a reusable band and adhesive tabs. The company says the system mechanically opens the nasal valve. The source report does not provide independent evidence of specific health or performance outcomes.

How does Intake plan to use the funding?

The company says it plans to expand into physical retail and specialty channels and make key hires. The report does not identify retailers, positions or a timeline.

Are the investment terms public?

No detailed terms were provided in the source report. It does not state the investment structure, company valuation or Camino’s ownership share.

Does the investment prove the device improves sleep or performance?

No. The investment announcement is not clinical evidence. The report describes the device’s intended design but does not establish that it improves sleep, recovery or athletic performance.

Source: athletechnews.com

Wellness content on this site is informational and not a substitute for professional medical guidance.
You May Also Like

When You’re Doing Everything Right But Still Feel Lonely

A Tiny Buddha essay recounts persistent loneliness, brief holiday connections in Asheville and questions about belonging in Buffalo.

Retatrutide Is One Click Away. That Doesn’t Make It Safe.

Retatrutide remains investigational, while online products may have unknown contents, strength and sterility, according to a physician’s report.

Clusters of Severe Stomach Illness Reported Across the U.S.

Multiple states report outbreaks of severe stomach illness with symptoms including explosive diarrhea; investigations are ongoing to identify causes.

Stiko-empfehlung Corona-impfung

Germany’s Standing Committee on Vaccination (Stiko) has issued new recommendations for COVID-19 booster shots for the upcoming year, prioritizing vulnerable groups.